{"product_id":"yi-pestle-analysis","title":"(YI) 111, Inc. PESTLE Analysis Research","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-List-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Competitive Advantage Starts with This Report\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eThis 111, Inc. PESTLE Analysis explains the political, economic, social, technological, legal, and environmental forces shaping the company and why they matter for strategy or investment. The page includes a real preview of the report so you can judge style and depth; purchase the full version to receive the complete, ready-to-use company-specific analysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003ePolitical factors\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthy China 2030\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHealthy China 2030 keeps policy support strong for wider medicine access, online care, and chronic disease management. With chronic diseases linked to over 80% of China’s deaths, 111, Inc. can benefit across B2B distribution and B2C pharmacy and telehealth. The plan’s 2030 life expectancy goal of 79 years also favors digital pharmacy and online consultation models.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVolume-based procurement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eChina’s volume-based procurement keeps drug prices under heavy pressure; in the 9th national round, average cuts were about 58%. For 111, Inc., that can squeeze gross margin in pharmacy and wholesale sales, especially on high-volume generics. So the Company has to manage product mix, sourcing, and fulfillment costs tightly to protect profit.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternet healthcare oversight\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eChina keeps tight oversight on online prescriptions, telemedicine, and e-pharmacy, and 111, Inc. must prove licensed consultations, proper dispensing, and full record keeping. With more than 1 billion internet users in China, scale is there, but regulators reward firms that can show traceable prescriptions and strong service quality. For 111, Inc., compliance is not optional; it is a key trust gate.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eLocal licensing in major cities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003e111, Inc. must keep municipal and provincial licenses aligned across at least 5 major operating hubs: Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan. That raises compliance cost and slows rollouts because each city can change filing, tax, pharmacy, and logistics rules on its own timeline.\u003c\/p\u003e\n\u003cp\u003eFor a multi-site model, one local policy shift can affect service continuity, delivery speed, and margins at the same time. The risk is higher in China’s layered system, where city rules sit under provincial oversight, so permits and renewals need constant tracking.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e5 key city permits to manage\u003c\/li\u003e\n\u003cli\u003eHigher admin load across regions\u003c\/li\u003e\n\u003cli\u003eLocal policy changes can hit operations fast\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003ePublic healthcare digitization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eChina’s public healthcare digitization keeps pushing care, pharmacy, and payment flows online, which helps 111, Inc. link hospitals, pharmacies, manufacturers, and patients through one platform. By end-2024, China’s basic medical insurance covered about 1.34 billion people, so digital procurement can reach a very large user base. This should support demand for data-led supply chain and pharmacy integration services.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eBig insured base supports platform scale.\u003c\/li\u003e\n\u003cli\u003eDigital procurement cuts manual steps.\u003c\/li\u003e\n\u003cli\u003ePharmacy links improve fulfillment speed.\u003c\/li\u003e\n\u003cli\u003eData services can gain more demand.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eChina’s Digital Health Tailwinds Meet Margin Pressure at 111, Inc.\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eChina’s policy tailwinds still support 111, Inc., especially under Healthy China 2030 and the shift to digital care. But tighter rules on online prescriptions and e-pharmacy mean licensed workflows, records, and audit trails stay central. Volume-based procurement also keeps pricing pressure high, with average cuts near 58% in the 9th round. Local permits across Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan add operating friction.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePolitical factor\u003c\/th\u003e\n\u003cth\u003eLatest data\u003c\/th\u003e\n\u003cth\u003eImpact on 111, Inc.\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePolicy support\u003c\/td\u003e\n\u003ctd\u003e1.34B insured; chronic disease share \u0026gt;80% of deaths\u003c\/td\u003e\n\u003ctd\u003eSupports scale in digital pharmacy\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrice control\u003c\/td\u003e\n\u003ctd\u003e~58% avg cut in 9th VBP round\u003c\/td\u003e\n\u003ctd\u003eضغطs margins on generics\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"product-includes\"\u003e\n\u003cdiv class=\"product-includes__container\"\u003e\n\u003ch2 id=\"product-includes-title\" class=\"product-includes__title\"\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-includes__grid\"\u003e\n\u003cdiv class=\"include-card\"\u003e\n\u003cdiv class=\"include-card__icon-wrap\"\u003e\n\u003cimg class=\"include-card__icon\" src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Detailed Word Document icon\"\u003e\n\u003c\/div\u003e\n\u003ch3 class=\"include-card__heading\"\u003e\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp class=\"include-card__text\"\u003eMaps the key political, economic, social, technological, environmental, and legal forces shaping 111, Inc.’s strategy, risks, and growth opportunities.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"include-card\"\u003e\n\u003cdiv class=\"include-card__icon-wrap\"\u003e\n\u003cimg class=\"include-card__icon\" src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Customizable Excel Spreadsheet icon\"\u003e\n\u003c\/div\u003e\n\u003ch3 class=\"include-card__heading\"\u003e\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp class=\"include-card__text\"\u003eA concise 111, Inc. PESTLE snapshot that quickly clarifies external risks and opportunities for faster strategy decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"include-card\"\u003e\n\u003cdiv class=\"include-card__icon-wrap\"\u003e\n\u003cimg class=\"include-card__icon\" src=\"\/cdn\/shop\/files\/GENERAL-Reference-Icon.svg\" alt=\"References icon\"\u003e\n\u003c\/div\u003e\n\u003ch3 class=\"include-card__heading\"\u003e\u003cstrong\u003eReference Sources\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp class=\"include-card__text\"\u003eLists primary reputable sources—industry reports, gov datasets, and benchmarks—so investors can verify claims fast and trace each key assumption.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eEconomic factors\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eChina consumer spending slowdown\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eChina’s weak consumer spending is a headwind for 111, Inc. because shoppers usually cut back first on non-essential wellness, beauty, and lifestyle items. Essential medicines are more defensive, so a sales mix tilted toward OTC and prescription products holds up better than a mix heavy in discretionary categories. In 2025, China’s retail recovery stayed uneven, making product mix a key driver of margin and revenue stability for 111, Inc.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare demand from aging\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eChina's 2024 data show 310.3 million people aged 60+ and 220.2 million aged 65+, so 111, Inc. faces steady demand for prescription refills and chronic-care products. An older base means more repeat pharmacy traffic, higher online reorder rates, and more need for consultation and fulfillment services. That supports 111, Inc.'s digital health and supply chain revenue mix.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrice-sensitive pharmacy market\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003e111, Inc. operates in a price-sensitive pharmacy market where both pharmacies and consumers compare medicine prices closely, so even small price gaps can shift demand. Online and offline rivals keep discounting, which compresses margins and makes scale, purchasing power, and faster inventory turns more important. For 111, Inc., lower unit costs and tighter procurement can matter more than pure sales growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eLoan services and credit risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003e111, Inc. uses online loan applications to help pharmacies and wholesalers access working capital, so credit conditions feed directly into platform use. When lenders tighten standards, approval rates fall and default risk rises, which can slow fee income and weaken partner growth.\u003c\/p\u003e\n\u003cp\u003eThat matters most for smaller pharmacy and wholesale clients, where cash flow can be uneven and borrowing costs move fast with policy rates. In tighter markets, 111, Inc. may see lower loan volume, slower monetization, and more pressure on credit controls.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLoan demand can rise, but credit supply can shrink.\u003c\/li\u003e\n\u003cli\u003eTighter lending lifts default risk and slows growth.\u003c\/li\u003e\n\u003cli\u003eWeaker credit conditions can cut platform monetization.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eLogistics and warehousing costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eWarehousing, delivery, and inventory carrying costs directly hit 111, Inc.'s margin, because healthcare goods must stay in stock and ship fast. In 2025, U.S. logistics still faced price pressure, with the CSCMP Logistics Managers' Index near 60 in March, a sign of expansion and sticky cost inflation. That makes O2O scale less valuable if transport, cold-chain, and storage costs rise faster than gross profit.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\u003cp\u003eHigh logistics cost cuts profit per order.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eStock gaps hurt healthcare service quality.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eCost inflation can blunt O2O scale gains.\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eChina’s Weak Demand Pressures 111, Inc. Margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eChina’s weak 2025 consumer demand still pressures 111, Inc., because shoppers trim non-essential wellness and beauty spend first. Aging demand supports repeat medicine use, but price cuts and tight credit can squeeze margins and slow partner growth. Higher logistics and inventory costs also limit O2O profit gains.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eFactor\u003c\/th\u003e\n\u003cth\u003eData\u003c\/th\u003e\n\u003cth\u003eImpact\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAging\u003c\/td\u003e\n\u003ctd\u003e310.3m 60+ in 2024\u003c\/td\u003e\n\u003ctd\u003eMore refill demand\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCredit\u003c\/td\u003e\n\u003ctd\u003eTighter lending in 2025\u003c\/td\u003e\n\u003ctd\u003eLower loan volume\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003e111, Inc. PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact PESTLE analysis of 111, Inc. you’ll receive after purchase—fully formatted, professionally structured, and ready to use for strategic or investment decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Social-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eSociological factors\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003e14 Yi Hao pharmacies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs of December 31, 2021, 111, Inc. operated 14 Yi Hao Pharmacy retail stores. Physical pharmacies still matter in China for trust, same-day pickup, and local service, especially for older or chronic-care patients. They also support the company’s O2O model, linking online ordering with offline access and faster fulfillment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAging and chronic care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eChina had 310.3 million people aged 60 and over in 2024, or 22.0% of the population, and 220.2 million were 65 and over. That aging mix lifts repeat medicine demand, follow-up support, and chronic care needs, which favors prescription fulfillment. For 111, Inc., pharmacies become service points for refills, counseling, and long-term disease management.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Social-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOnline health consultation adoption\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOnline health consultations are now a normal first step for routine questions, so 111, Inc. can cut the gap between diagnosis and purchase. This matters because digital care keeps users in the same app path, which can lift repeat visits and pharmacy conversion. In China, internet healthcare users reached 330 million in 2024, showing the channel is already mainstream.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eTraditional Chinese medicine demand\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003e111, Inc. benefits from demand for both Western and traditional Chinese OTC drugs, since familiar use cases widen its addressable market. In China, mixed treatment is common, so 111’s dual-category catalog fits everyday buying habits and supports repeat orders. That cultural preference makes TCM a steady demand driver, not a niche add-on.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDual OTC mix widens demand.\u003c\/li\u003e\n\u003cli\u003eTCM fits mixed-treatment habits.\u003c\/li\u003e\n\u003cli\u003eFamiliarity supports repeat buying.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003ePersonal care and family products\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003e111, Inc.’s personal care and family products line spans skincare, birth control, sexual wellness, and infant care, matching everyday household health demand. In China, the aging population reached 296.97 million people aged 60+ in 2023, while births totaled 9.02 million, keeping family-care needs broad and recurring. This mix can lift basket size and reduce reliance on prescription-only sales.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSkincare supports repeat purchases\u003c\/li\u003e\n\u003cli\u003eInfant care taps family spending\u003c\/li\u003e\n\u003cli\u003eSexual wellness adds higher-margin variety\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eChina’s Aging, Digital Shift Fuels 111, Inc.’s O2O Pharmacy Growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eChina’s aging, urban, and digital-first habits support 111, Inc.’s pharmacy and O2O model. In 2024, people aged 60+ reached 310.3 million, 22.0% of the population, while internet healthcare users hit 330 million, keeping refills, counseling, and repeat orders online and offline.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eDriver\u003c\/th\u003e\n\u003cth\u003eData\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAge 60+\u003c\/td\u003e\n\u003ctd\u003e310.3M, 22.0%, 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInternet healthcare\u003c\/td\u003e\n\u003ctd\u003e330M users, 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Technological-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eTechnological factors\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOnline-to-offline ecosystem\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003e111, Inc.'s O2O model links online ordering to offline pharmacy pickup and delivery, so customers can buy and get local fulfillment fast. The company says its network covers more than 70,000 partner pharmacies, which helps widen access and keep orders close to users. This setup improves convenience and supports repeat purchases because stock, price, and service stay connected in one flow.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eElectronic prescription fulfillment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003e111, Inc. uses electronic prescription fulfillment to speed consumer delivery, but it depends on secure digital workflows and exact drug matching. In the U.S., more than 90% of prescriptions are now sent electronically, which makes clean eRx handling a core operating need. Faster routing can cut fulfillment time and lower manual-entry errors, which matters when even small mistakes can delay patient access.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Technological-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarketplace for third-party vendors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003e111, Inc.'s marketplace lets third-party vendors sell to pharmacies directly, widening assortment and improving sourcing flexibility. That matters when stockouts can hit same-day refill demand.\u003c\/p\u003e\n\u003cp\u003eThe trade-off is tighter platform control: SKU, price, and inventory data must sync fast across vendors and pharmacies to avoid errors and delays.\u003c\/p\u003e\n\u003cp\u003eIn 2025, pharma e-commerce scale kept rising in China, so vendor depth can boost GMV, but only if data matching stays clean.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eSupply chain integration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003e111, Inc.'s data and supply chain integration tools help partners see inventory in real time, automate orders, and plan replenishment faster. That matters in China’s pharma trade, where even small stock gaps can cut sales and raise expiry risk. Better integration can reduce stockouts and excess stock, which supports working capital control and service levels.\u003c\/p\u003e\n\u003cp\u003eAs of 2025, 111, Inc. still ties platform data to supplier and pharmacy flows, making order timing and inventory turns more efficient. In practice, tighter integration can lower manual errors and shorten refill cycles, which is a direct edge in a market where speed and fill rates drive repeat demand.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eReal-time inventory visibility\u003c\/li\u003e\n\u003cli\u003eFaster ordering and replenishment\u003c\/li\u003e\n\u003cli\u003eFewer stockouts and overstocks\u003c\/li\u003e\n\u003cli\u003eBetter working capital use\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eSoftware development and IT support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003e111, Inc.’s software development and IT support are core to its healthcare commerce model, because order routing, payment flow, and provider links all depend on stable platforms and secure data handling. In 2025, cybersecurity and uptime were not optional: even one serious outage can disrupt prescriptions, inventory, and settlement. Technology strength is therefore a direct operating asset, not just a back-office cost.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eStable systems protect order fulfillment.\u003c\/li\u003e\n\u003cli\u003eSecure data flow supports compliance.\u003c\/li\u003e\n\u003cli\u003eScalable platforms enable growth.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003e111, Inc.’s Tech Backbone Powers Faster, Smarter Pharmacy Fulfillment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003e111, Inc.'s tech stack is the core of its O2O pharmacy model: more than 70,000 partner pharmacies, real-time inventory, and fast order routing.\u003c\/p\u003e\n\u003cp\u003eWith more than 90% of U.S. prescriptions now e-sent, secure eRx handling and uptime are key to cut errors and speed fulfillment.\u003c\/p\u003e\n\u003cp\u003eIn 2025, tighter data sync across vendors and pharmacies also helped reduce stockouts, overstocks, and working-capital drag.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePartner pharmacies\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;70,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eU.S. eRx share\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;90%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMain tech risk\u003c\/td\u003e\n\u003ctd\u003eOutage or data mismatch\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Legal-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eLegal factors\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePIPL and data security\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003e111, Inc. processes consumer, pharmacy, and prescription data, so China’s PIPL and Data Security Law are central to its online health and lending services. PIPL can fine companies up to RMB 50 million or 5% of annual revenue, and can also suspend operations. That makes tight consent, storage, and cross-border transfer controls a must.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDrug sales licensing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003e111, Inc. depends on valid pharmaceutical licenses for retail and wholesale drug sales, so any lapse can stop orders and deliveries fast. Prescription drugs face tighter control than over-the-counter items, which raises compliance work across the platform. In China, this licensing risk can hit both revenue flow and inventory turnover at once.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Legal-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOnline consultation rules\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIn 2025, 111, Inc. still faces tight supervision on online consultations, since medical advice, doctor licensing, and platform conduct all fall under health and drug rules. Every visit record, doctor credential, and e-prescription step must be traceable, or the platform risks compliance action. This is most sensitive when a consult leads to prescription fulfillment, where errors can trigger patient harm and regulator scrutiny.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eAdvertising and product claims\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003e111, Inc. faces tight rules on ads for healthcare, supplement, device, and personal care products, because search, marketplace, and retail claims can’t imply unproven treatment benefits. In the U.S., the FDA and FTC can act fast on misleading claims, and the FTC has said ads must be backed by competent and reliable evidence. \u003c\/p\u003e\n\u003cp\u003eThat raises compliance risk for product pages, paid search, and seller content, where a single claim can trigger takedowns, warning letters, or fines. For 111, Inc., the key issue is not just what the product does, but how every headline, keyword, and promo line is worded. \u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eStrict claim review across all channels\u003c\/li\u003e\n\u003cli\u003eNo misleading therapeutic wording\u003c\/li\u003e\n\u003cli\u003eSearch ads need proof-backed copy\u003c\/li\u003e\n\u003cli\u003eMarketplace listings face takedown risk\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003ePlatform and lending compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003e111, Inc.'s marketplace and online loan services face tight platform governance and financial compliance checks, so partner screening, anti-fraud controls, and clear fee and risk disclosure are core legal needs. In China, lending and internet-platform rules can change fast, and that can slow user growth or limit monetization if controls slip. For a platform like 111, Inc., compliance is not back-office work; it directly affects revenue speed and regulatory risk.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eScreen lenders and merchants before onboarding\u003c\/li\u003e\n\u003cli\u003eTrack fraud and suspicious loan activity\u003c\/li\u003e\n\u003cli\u003eDisclose rates, fees, and borrower risks\u003c\/li\u003e\n\u003cli\u003eExpect legal reviews to curb growth\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eChina compliance risks could hit 111, Inc. with fines and sales halts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eLegal risk for 111, Inc. in 2025-2026 is driven by China’s PIPL, Data Security Law, and pharmacy rules. PIPL fines can reach RMB 50 million or 5% of annual revenue, and service suspension is possible. Online care, ads, and lending need strict licensing, consent, and claim checks.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eRisk\u003c\/th\u003e\n\u003cth\u003eKey data\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrivacy\u003c\/td\u003e\n\u003ctd\u003eUp to RMB 50m or 5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAds\u003c\/td\u003e\n\u003ctd\u003eProof-backed claims\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLicenses\u003c\/td\u003e\n\u003ctd\u003eCan halt sales\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Enviromental-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eEnvironmental factors\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePackaging waste from e-commerce\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOnline medicine and wellness sales at 111, Inc. create more parcel and secondary packaging waste, which raises pressure to use recyclable materials and cut excess fill. In China, express parcel volume topped 130 billion pieces in 2023, so even small changes in pack design can have a large waste impact. For urban buyers, lighter, recyclable packaging can lift brand image, while visible waste can hurt trust.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnergy use in warehouses\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003e111, Inc.'s multi-region inventory model makes warehouse power a real cost driver: lighting, refrigeration, and IT systems all add to the bill. Energy-efficiency upgrades like LED lighting can cut lighting power use by up to 75%, which lowers both opex and emissions. That matters more as e-commerce logistics grows, with warehouse electricity often tied to around-the-clock operations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Enviromental-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCold chain and temperature control\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFor 111, Inc., cold chain rules matter because many medical and wellness products must stay within tight temperature ranges from warehouse to last-mile delivery. The WHO says about 50% of vaccines are wasted each year, and many losses are linked to temperature breaks, so product integrity and compliance are direct risk points. This also raises logistics costs through refrigerated storage, monitoring, and faster transit.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eGreen delivery expectations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eChina’s express sector handled 193.67 billion parcels in 2024, so even small route gains can cut fuel use and emissions. For 111, Inc., healthcare e-commerce has to keep next-day speed while lowering carbon per delivery.\u003c\/p\u003e\n\u003cp\u003eRoute optimization and shipment consolidation are the main tools. They reduce empty miles, lower delivery cost, and help meet cleaner-logistics rules without slowing service.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 China parcels: 193.67 billion\u003c\/li\u003e\n\u003cli\u003eSpeed still matters in healthcare\u003c\/li\u003e\n\u003cli\u003eConsolidation cuts emissions and cost\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eClimate and disruption risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eExtreme weather and local outages can slow 111, Inc.’s delivery routes, cut store traffic, and force tighter inventory buffers. For a healthcare platform, demand stays non-optional, but service breaks can hit trust fast, so resilient warehousing and backup carriers matter more than ever.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eWeather can delay last-mile delivery.\u003c\/li\u003e\n\u003cli\u003eFulfillment reliability protects healthcare demand.\u003c\/li\u003e\n\u003cli\u003eRedundant supply chains reduce disruption risk.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSupply-chain resilience is now a core operating need, not a nice-to-have.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003e111, Inc.: Cutting Waste in China’s High-Volume Delivery Chain\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnvironmental pressure on 111, Inc. centers on packaging waste, cold-chain power use, and lower-emission delivery. China’s express sector handled 193.67 billion parcels in 2024, so small gains in route planning and pack design can cut waste and fuel use fast. WHO says about 50% of vaccines are wasted each year, making temperature control and backup logistics critical.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eFactor\u003c\/th\u003e\n\u003cth\u003eData\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eChina parcels 2024\u003c\/td\u003e\n\u003ctd\u003e193.67 billion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLED lighting savings\u003c\/td\u003e\n\u003ctd\u003eUp to 75%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWHO vaccine waste\u003c\/td\u003e\n\u003ctd\u003eAbout 50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"DCF Analyst","offers":[{"title":"Default Title","offer_id":57235202179337,"sku":"yi-pestle-analysis","price":5.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0942\/8045\/0313\/files\/yi-pestle-analysis.webp?v=1785736755","url":"https:\/\/dcfanalyst.com\/products\/yi-pestle-analysis","provider":"DCF Analyst","version":"1.0","type":"link"}